LUPUS NEXUS LANDMARK STUDY: A PROSPECTIVE REGISTRY AND BIOREPOSITORY

Summary

The Lupus Research Alliance is launching the Lupus Landmark Study, a groundbreaking health research study that will improve personalized treatments for people living with lupus. This will be the largest study of its kind in lupus research, and will include 3,500 adults diagnosed with lupus.

The study aims to transform lupus research and drug development through the creation of a research platform. The platform will be a source of important clinical data, patient reported data, and biological samples that will catalyze global collaboration, innovation, and precision medicine approaches in lupus.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 100

Inclusion criteria:

Participants must be:

Able to understand and comply with study procedures and voluntarily sign a written informed consent document

Age18 years or older at the time of enrolment

Have a diagnosis of Systemic Lupus Erythematosis



Exclusion criteria:

Those who are currently pregnant.
Those whose age is less than 18 years.

Participate

Fill out the following form if you want to participate in this research

Method of contact

UCalgary Notice of Collection
The University of Calgary (UCalgary) respects your privacy and is committed to ensuring the privacy of all students, staff, and community members. Your personal information is being collected under the authority of section 4(c) of the Protection of Privacy Act (POPA). It will be collected, used and disclosed for the purposes outlined in UCalgary’s Notice of Collection, Use and Disclosure of Personal Information and managed in accordance with UCalgary’s Privacy Management Program. Your personal information may be input into automated systems to generate content or make decisions, recommendations, or predictions. If you have questions regarding this notice or UCalgary’s collection, use, or disclosure of your personal information, please contact accessandprivacy@ucalgary.ca.

Additional information

Contact information

Lupus Research Team

Principal investigator:

Ann Clarke

Clinical trial:

No

REB-ID:

REB23-1555